Nalls Sherbakoff Group’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Nalls Sherbakoff Group’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$2K	Buy	+500	New	+$1.76K	﹤0.01%	359

Other funds holding BDSI

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AOWM

Alpha Omega Wealth Management Richmond, Virginia $657M AUM 22.33% 1-Year Est. Return

Nalls Sherbakoff Group's BDSI Position: Q4 2018 in Review

Nalls Sherbakoff Group opened a new position in BioDelivery Sciences International, Inc. (BDSI) in Q4 2018: 500 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #359 among its holdings.

86 funds tracked by Wall St. Rank hold BDSI as of Q4 2018.

Nalls Sherbakoff Group held 500 shares of BioDelivery Sciences International, Inc. worth $2K as of Q4 2018.
BioDelivery Sciences International, Inc. was a new Nalls Sherbakoff Group position in Q4 2018.
BioDelivery Sciences International, Inc. made up ﹤0.01% of Nalls Sherbakoff Group's portfolio in Q4 2018, its #359 holding.
86 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2018.

Based on Nalls Sherbakoff Group's 13F filing for Q4 2018, filed 13 Feb 2019.